Top

Published in:

01-03-2019 | Commentary

What do we know about the trends in incidence of childhood-onset type 1 diabetes?

Authors: Jean M. Lawrence, Elizabeth J. Mayer-Davis

Published in: Diabetologia | Issue 3/2019

Excerpt

Type 1 diabetes requires intensive ongoing management and may lead to complications that affect multiple organ systems. Concern has been raised about the increasing incidence of type 1 diabetes worldwide, given the impact that type 1 diabetes has on quality of life and the long-term cost to healthcare systems and individuals with diabetes and their families. …

Patterson CC, Harjutsalo V, Rosenbauer J et al (2018) Trends and cyclic variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25-year period 1989–2013: a multicentre prospective registration study. Diabetologia. https://doi.org/10.1007/s00125-018-4763-3

Patterson CC, Gyürüs E, Rosenbauer J et al (2012) Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 55(8):2142–2147. https://doi.org/10.1007/s00125-012-2571-8 CrossRefPubMed

Mayer-Davis EJ, Lawrence JM, Dabelea D et al (2017) Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 376(15):1419–1429. https://doi.org/10.1056/NEJMoa1610187 CrossRefPubMedPubMedCentral

Fox DA, Islam N, Sutherland J, Reimer K, Amed S (2018) Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth. Pediatr Diabetes 19(3):501–505. https://doi.org/10.1111/pedi.12566 CrossRefPubMed

The DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23(8):857–866. https://doi.org/10.1111/j.1464-5491.2006.01925.x CrossRef

Hamman RF, Bell RA, Dabalea D et al (2014) The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care 37(12):3336–3344. https://doi.org/10.2337/dc14-0574

Weng J, Zhou Z, Guo L et al (2018) Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 360:j5295. https://doi.org/10.1136/bmj.j5295 CrossRefPubMedPubMedCentral

Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368CrossRef

Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358(9277):221–229. https://doi.org/10.1016/S0140-6736(01)05415-0 CrossRefPubMed

10.

Redondo MJ, Steck AK, Pugliese A (2018) Genetics of type 1 diabetes. Pediatr Diabetes 19(3):346–353. https://doi.org/10.1111/pedi.12597 CrossRefPubMed

11.

Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41(6):703–707. https://doi.org/10.1038/ng.381 CrossRefPubMedPubMedCentral

12.

Rewers M, Hyöty H, Lernmark Å et al (2018) The Environmental Determinants of Diabetes in the Young (TEDDY) study: 2018 update. Curr Diab Rep 18(12):136. https://doi.org/10.1007/s11892-018-1113-2 CrossRefPubMed

13.

Cherubini V, Hermann J, Lesson K et al (2018) DKA at onset of paediatric type 1 diabetes across the world: results from a Joint International Project. Pediatr Diabetes 19(Suppl 26):28–29 (Abstract)

14.

Elding Larsson H, Vehik K, Bell R et al (2011) Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34(11):2347–2352. https://doi.org/10.2337/dc11-1026 CrossRefPubMedPubMedCentral

Title: What do we know about the trends in incidence of childhood-onset type 1 diabetes?
Authors: Jean M. Lawrence
Elizabeth J. Mayer-Davis
Publication date: 01-03-2019
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 3/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-018-4791-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2019

Reduced skeletal-muscle perfusion and impaired ATP release during hypoxia and exercise in individuals with type 2 diabetes

DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway

One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort

lncRNA H19 prevents endothelial–mesenchymal transition in diabetic retinopathy

Association and risk factors of chronic kidney disease and incident diabetes: a nationwide population-based cohort study

Cardiovascular outcome trials of glucose-lowering medications: an update

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage